Recent Quotes

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-03
REV		(EXPECTED)2021-08-03

Q1 2021		Est.		Actual		Surprise
EPS		-0.430		-0.410		0.0200
REV		8.970M		11.122M		2.152M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
AQST	Aquestive Therapeutics	4.07	0.01	0.25%		148.9M

Aquestive Therapeutics Frequently Asked Questions

How do I buy Aquestive Therapeutics (AQST) stock?

You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.

View our list of the best stock brokerages.

Who are Aquestive Therapeutics's (AQST) competitors?

Other companies in Aquestive Therapeutics’s space includes: Graybug Vision (NASDAQ:GRAY), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and SCYNEXIS (NASDAQ:SCYX).

What is the target price for Aquestive Therapeutics (AQST) stock?

The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by RBC Capital on September 28, 2020. The analyst firm set a price target for 7.00 expecting AQST to rise to within 12 months (a possible 71.99% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Aquestive Therapeutics (AQST)?

The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.07 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does Aquestive Therapeutics (AQST) pay a dividend?

There are no upcoming dividends for Aquestive Therapeutics.

When is Aquestive Therapeutics (NASDAQ:AQST) reporting earnings?

Aquestive Therapeutics’s Q2 earnings are confirmed for after-market on August 3, 2021.

Is Aquestive Therapeutics (AQST) going to split?

There is no upcoming split for Aquestive Therapeutics.

What sector and industry does Aquestive Therapeutics (AQST) operate in?

Aquestive Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.